Your browser doesn't support javascript.
loading
Characterization of the IncFII-IncFIB(pB171) Plasmid Carrying bla NDM-5 in Escherichia coli ST405 Clinical Isolate in Japan.
Takayama, Yoko; Sekizuka, Tsuyoshi; Matsui, Hidehito; Adachi, Yuzuru; Eda, Ryotaro; Nihonyanagi, Shin; Wada, Tatsuhiko; Matsui, Mari; Suzuki, Satowa; Takaso, Masashi; Kitasato, Hidero; Kuroda, Makoto; Hanaki, Hideaki.
Afiliación
  • Takayama Y; Department of Infection Control and Infectious Diseases, Research and Development Center for New Medical Frontiers, Kitasato University School of Medicine, Kanagawa, Japan.
  • Sekizuka T; Department of Infection Control and Prevention, Kitasato University Hospital, Kanagawa, Japan.
  • Matsui H; Pathogen Genomics Center, National Institute of Infectious Diseases, Tokyo, Japan.
  • Adachi Y; Infection Control Research Center, Kitasato Institute for Life Sciences, Kitasato University, Tokyo, Japan.
  • Eda R; Infection Control Research Center, Kitasato Institute for Life Sciences, Kitasato University, Tokyo, Japan.
  • Nihonyanagi S; Department of Microbiology, School of Allied Health Sciences, Kitasato University, Kanagawa, Japan.
  • Wada T; Department of Infection Control and Prevention, Kitasato University Hospital, Kanagawa, Japan.
  • Matsui M; Department of Infection Control and Prevention, Kitasato University Hospital, Kanagawa, Japan.
  • Suzuki S; Antimicrobial Resistance Research Center, National Institute of Infectious Diseases, Tokyo, Japan.
  • Takaso M; Antimicrobial Resistance Research Center, National Institute of Infectious Diseases, Tokyo, Japan.
  • Kitasato H; Department of Orthopaedic Surgery, Kitasato University School of Medicine, Kanagawa, Japan.
  • Kuroda M; Department of Microbiology, School of Allied Health Sciences, Kitasato University, Kanagawa, Japan.
  • Hanaki H; Pathogen Genomics Center, National Institute of Infectious Diseases, Tokyo, Japan.
Infect Drug Resist ; 13: 561-566, 2020.
Article en En | MEDLINE | ID: mdl-32110066
ABSTRACT

PURPOSE:

New Delhi metallo-ß-lactamase 5 (NDM-5) shows stronger resistance to carbapenems and broad-spectrum cephalosporins than NDM-1 because NDM-5 differs from NDM-1 by two amino acid substitutions. In this study, our aim was to characterize a NDM-5-producing Escherichia coli isolate KY1497 from a patient with urinary tract infection in Japan, who had no recent history of overseas travel. PATIENTS AND

METHODS:

NDM-5-producing E. coli isolate KY1497 was detected in the urine sample of a patient hospitalized in a tertiary hospital in Japan. The complete genome sequence of isolate KY1497 was determined by short- and long-read sequencing with hybrid assembly, followed by multilocus sequence typing (MLST), core-genome phylogeny analysis, plasmid analysis, and transconjugation experiments.

RESULTS:

KY1497 was classified as ST405 by MLST, and core-genome phylogeny exhibited the closest lineage to the clinical isolates in Nepal (IOMTU605) and Canada (FDAARGOS_448). KY1497 harbors bla NDM-5 in the IncFII-IncFIB(pB171) replicon plasmid (pKY1497_1, 123,767 base pairs). Plasmid analysis suggested that the cognate plasmids of pKY1497_1 have a minor plasmid background, rather than the globally disseminated IncX3 plasmid carrying bla NDM-5. Transconjugation analysis revealed that pKY1497_1 is transmissible to the recipient E. coli J53 strain.

CONCLUSION:

We characterized a novel Inc replicon plasmid (IncFII-IncFIB[pB171]) carrying bla NDM-5 and its host E. coli strain. NDMs are associated with a high risk of infection worldwide because of their antibiotic resistance and untreatable and hard-to-treat infections. Other patients in the hospital showed negative results for carbapenem-resistant Enterobacteriaceae. As NDM-producing strains are only sporadically detected in Japan, attention should be provided to the community prevalence of NDM-producing E. coli strains to prevent nosocomial infections.
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Infect Drug Resist Año: 2020 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Infect Drug Resist Año: 2020 Tipo del documento: Article País de afiliación: Japón